Qsemble Capital Management, LP Charles River Laboratories International, Inc. Transaction History
Qsemble Capital Management, LP
- $527 Billion
- Q2 2024
A detailed history of Qsemble Capital Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Qsemble Capital Management, LP holds 1,187 shares of CRL stock, worth $235,833. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,187
Previous 3,672
67.67%
Holding current value
$235,833
Previous $995 Million
75.35%
% of portfolio
0.05%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$415 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$379 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$272 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...